CytomX Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $353.5M | $339.4M | $205.5M |
| FY2022 | $326.6M | $260.9M | $193.7M |
| FY2023 | $249.2M | $201.8M | $17.2M |
| FY2024 | $121.0M | $120.5M | $38.1M |
| FY2025 | $52.6M | $151.6M | $12.7M |